Quick Look Market Closing Price:
At the close: Dow +0.02% to 12106. S&P +0.21% to 1244. Nasdaq -1.46% to 2249.
Treasurys: 30-year -0.67%. 10-yr -0.19%. 5-yr -0.13%.
Commodities: Crude +1.71% to $98.9. Gold +0.01% to $1617.75.
Currencies: Euro -0.27% vs. dollar. Yen +0.26%. Pound -0.1%.
After Hours News:
Tibco (TIBX) guides on its earnings call for FQ1 revenue of $220M-$225M ($215.8M consensus) and EPS of $0.18-$0.19 ($0.18 consensus). Tibco's shares, which were down as much as 5% following its FQ4 report, are now up 1.4% AH.
Transcept Pharmaceuticals (TSPT) receives a $10M milestone payment from Purdue Pharma following the FDA's inclusion of Intermezzo formulation patents in its Orange Book last week. The payment is part of an agreement between the two parties for the U.S. commercialization of the drug to be launched in Q2 of 2012. Shares +0.7% AH.
Finish Line (FINL) drops 2.2% AH after reporting FQ3 revenue of $282M (+8% Y/Y) and EPS of $0.11; the former beat by $9.3M, but the latter was just in-line. Same-store sales rose 7.7% Y/Y, and the company's gross margin came in at 32.2% (down from FQ2's 35.1%). Finish Line is also reporting its same-store sales rose 7% Y/Y for the first 3 weeks of the holiday season
Herman Miller (MLHR) posts a mixed FQ2 with its EPS meeting estimates but missing on revenue, despite an extra week of sales during the quarter. New orders declined 4% Y/Y to $440M. Shares -2.3% AH.
http://daytradingstock-blog.blogspot.com/